Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

SABCS 2021 | Impact of genomic testing on treatment decision-making in breast cancer

Corey Speers • 9 Dec 2021
SABCS 2021
Breast Cancer

Corey Speers, MD, PhD, University of Michigan Medicine, Ann Arbor, MI, discusses how the availability of genomic testing has affected treatment decision-making over the last decade. This interview took place at the San Antonio Breast Cancer Symposium 2021 in San Antonio.

More from Corey Speers

1:11
Endocrine therapy treatment radiosensitizes ER+ breast cancer
Corey Speers • 9 Dec 2021
1:27
16-gene signature identifies early-stage invasive breast cancer patients who may omit radiotherapy
Corey Speers • 9 Dec 2021
1:18
Predicted sensitivity to ET (SET2,3 index): results of an analysis of the SWOG S8814 trial
Corey Speers • 9 Dec 2021

Related Videos

4:12
PETRA: saruparib in solid tumors with BRCA1/2, PALB2 or RAD51C/D mutations
Timothy Yap • 7 Apr 2024
1:03
The future of peptide-conjugated drugs in oncology
Mitchell Elliott • 8 Apr 2024
1:26
The clinical applications of MRD in breast cancer
Mitchell Elliott • 8 Apr 2024
1:47
CCNG1 as a biomarker for DRG-101 gene therapy in cancer
Vaishali Kumar • 8 Apr 2024
The content of VJOncology is intended for healthcare professionals